Ticker

Analyst Price Targets — CSLLY

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
August 9, 2022 7:01 pmChris CooperGoldman Sachs$153.50$51.49TheFly CSL reinstated with a Neutral at Goldman Sachs

Latest News for CSLLY

CSLLY vs. ACAD: Which Stock Should Value Investors Buy Now?

Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both CSL Limited Sponsored ADR (CSLLY) and Acadia Pharmaceuticals (ACAD). But which of these two stocks is more attractive to value investors?

Zacks Investment Research • Apr 14, 2026
CSLLY or ARGX: Which Is the Better Value Stock Right Now?

Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both CSL Limited Sponsored ADR (CSLLY) and argenex SE (ARGX). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks Investment Research • Mar 24, 2026
CSLLY vs. ARGX: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either CSL Limited Sponsored ADR (CSLLY) or argenex SE (ARGX). But which of these two stocks is more attractive to value investors?

Zacks Investment Research • Mar 23, 2026
Analyzing CSL (OTCMKTS:CSLLY) and Ascentage Pharma Group International (NASDAQ:AAPG)

CSL (OTCMKTS:CSLLY - Get Free Report) and Ascentage Pharma Group International (NASDAQ: AAPG - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation. Volatility and Risk CSL has a beta

Defense World • Mar 12, 2026
CSL announces expansion of Illinois plasma therapy manufacturing facility

New $1.5 billion investment builds on over $3 billion already spent on CSL's U.S. operations since 2018 Expansion will create at least 300 new jobs and enhance production of plasma-derived therapies and albumin through advanced manufacturing capabilities Governor Pritzker, local officials and CSL leadership underscore the expansion's role in supporting patients and strengthening the regional economy KING OF PRUSSIA,…

PRNewsWire • Mar 9, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for CSLLY.

No Senate trades found for CSLLY.

House Trades Disclosures

NameTransaction DateTypeAssetAmountLink

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top